PRKCB and Cognitive impairment: This section focuses on the four key subtypes—PKCα, PKCβ, PKCε, and PKCδ—systematically analyzing their double‐edged roles and targeted intervention strategies in conditions such as sensory abnormalities, stroke, and cognitive impairments.